MYADM | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
fibroblast	32 studies	43% ± 17%	Explore
pericyte	28 studies	41% ± 18%	Explore
classical monocyte	25 studies	41% ± 19%	Explore
endothelial cell	24 studies	29% ± 11%	Explore
smooth muscle cell	24 studies	40% ± 18%	Explore
conventional dendritic cell	24 studies	41% ± 18%	Explore
CD8-positive, alpha-beta T cell	22 studies	27% ± 9%	Explore
macrophage	21 studies	30% ± 10%	Explore
T cell	20 studies	28% ± 12%	Explore
mast cell	19 studies	45% ± 20%	Explore
non-classical monocyte	19 studies	33% ± 18%	Explore
CD4-positive, alpha-beta T cell	19 studies	31% ± 12%	Explore
natural killer cell	18 studies	26% ± 11%	Explore
monocyte	17 studies	32% ± 12%	Explore
B cell	16 studies	26% ± 11%	Explore
connective tissue cell	15 studies	36% ± 13%	Explore
myofibroblast cell	14 studies	48% ± 17%	Explore
endothelial cell of lymphatic vessel	13 studies	35% ± 18%	Explore
dendritic cell	12 studies	48% ± 20%	Explore
plasmacytoid dendritic cell	12 studies	34% ± 17%	Explore
mature NK T cell	12 studies	28% ± 8%	Explore
basal cell	12 studies	27% ± 8%	Explore
gamma-delta T cell	12 studies	34% ± 17%	Explore
myeloid cell	10 studies	38% ± 22%	Explore
neutrophil	9 studies	33% ± 10%	Explore
mucosal invariant T cell	9 studies	32% ± 13%	Explore
regulatory T cell	9 studies	27% ± 8%	Explore
capillary endothelial cell	9 studies	27% ± 9%	Explore
type I pneumocyte	8 studies	32% ± 17%	Explore
CD16-negative, CD56-bright natural killer cell, human	8 studies	31% ± 15%	Explore
naive B cell	8 studies	32% ± 12%	Explore
alveolar macrophage	7 studies	32% ± 13%	Explore
leukocyte	7 studies	30% ± 13%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	7 studies	23% ± 11%	Explore
effector memory CD8-positive, alpha-beta T cell	7 studies	30% ± 12%	Explore
endothelial cell of artery	7 studies	24% ± 6%	Explore
hematopoietic stem cell	7 studies	38% ± 11%	Explore
memory B cell	7 studies	25% ± 11%	Explore
CD8-positive, alpha-beta memory T cell	7 studies	37% ± 19%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	36% ± 18%	Explore
CD16-positive, CD56-dim natural killer cell, human	6 studies	29% ± 11%	Explore
epithelial cell	6 studies	35% ± 23%	Explore
plasma cell	5 studies	23% ± 5%	Explore
plasmablast	5 studies	31% ± 12%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	25% ± 12%	Explore
mononuclear phagocyte	5 studies	32% ± 15%	Explore
abnormal cell	5 studies	23% ± 7%	Explore
precursor B cell	5 studies	44% ± 9%	Explore
pro-B cell	5 studies	35% ± 6%	Explore
ciliated cell	5 studies	34% ± 13%	Explore
innate lymphoid cell	5 studies	31% ± 15%	Explore
granulocyte	5 studies	49% ± 14%	Explore
endothelial cell of vascular tree	5 studies	40% ± 18%	Explore
goblet cell	5 studies	25% ± 6%	Explore
hematopoietic precursor cell	4 studies	47% ± 12%	Explore
effector CD8-positive, alpha-beta T cell	4 studies	21% ± 6%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	27% ± 11%	Explore
mesothelial cell	4 studies	54% ± 26%	Explore
immature B cell	4 studies	42% ± 15%	Explore
adventitial cell	4 studies	41% ± 20%	Explore
CD4-positive helper T cell	4 studies	37% ± 26%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	28% ± 9%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	32% ± 2%	Explore
vein endothelial cell	4 studies	19% ± 3%	Explore
enteroendocrine cell	4 studies	29% ± 5%	Explore
secretory cell	4 studies	46% ± 19%	Explore
pancreatic A cell	3 studies	24% ± 2%	Explore
lymphocyte	3 studies	42% ± 12%	Explore
intermediate monocyte	3 studies	58% ± 16%	Explore
glial cell	3 studies	24% ± 8%	Explore
T follicular helper cell	3 studies	35% ± 18%	Explore
group 3 innate lymphoid cell	3 studies	43% ± 20%	Explore
T-helper 17 cell	3 studies	42% ± 22%	Explore
double negative thymocyte	3 studies	31% ± 13%	Explore
double-positive, alpha-beta thymocyte	3 studies	36% ± 21%	Explore
progenitor cell of mammary luminal epithelium	3 studies	37% ± 7%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	13 studies	28% ± 9%	Explore
peripheral blood	12 studies	30% ± 13%	Explore
intestine	7 studies	30% ± 10%	Explore
kidney	4 studies	25% ± 4%	Explore
bone marrow	4 studies	28% ± 8%	Explore
uterus	4 studies	52% ± 11%	Explore
breast	4 studies	32% ± 2%	Explore
pancreas	3 studies	24% ± 6%	Explore
placenta	3 studies	20% ± 4%	Explore
prostate	3 studies	18% ± 3%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	100%	8971.50	459 / 459	98%	121.84	1099 / 1118
ovary	99%	7096.84	178 / 180	98%	93.42	423 / 430
intestine	99%	11575.30	956 / 966	98%	87.87	516 / 527
prostate	95%	6887.10	232 / 245	98%	78.99	494 / 502
lung	100%	10774.81	576 / 578	91%	76.95	1050 / 1155
thymus	95%	4991.24	622 / 653	94%	73.31	566 / 605
stomach	87%	6708.93	312 / 359	99%	120.46	283 / 286
skin	93%	6654.42	1684 / 1809	87%	69.70	410 / 472
esophagus	81%	9916.18	1176 / 1445	95%	110.21	173 / 183
uterus	99%	18652.12	169 / 170	74%	64.08	338 / 459
bladder	100%	9557.19	21 / 21	72%	48.20	361 / 504
adrenal gland	53%	1320.40	136 / 258	81%	47.99	186 / 230
pancreas	38%	1030.52	125 / 328	95%	124.90	169 / 178
kidney	42%	1389.10	37 / 89	88%	82.43	794 / 901
blood vessel	100%	16504.09	1335 / 1335	0%	0	0 / 0
adipose	100%	12319.58	1202 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	99%	50.57	79 / 80
heart	95%	6177.47	818 / 861	0%	0	0 / 0
spleen	90%	3097.15	218 / 241	0%	0	0 / 0
peripheral blood	90%	10899.46	836 / 929	0%	0	0 / 0
brain	26%	671.79	694 / 2642	61%	22.48	431 / 705
liver	18%	502.01	40 / 226	67%	29.64	272 / 406
tonsil	0%	0	0 / 0	67%	32.15	30 / 45
lymph node	0%	0	0 / 0	55%	20.82	16 / 29
muscle	20%	516.80	157 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0090038	Biological process	negative regulation of protein kinase C signaling
GO_0030837	Biological process	negative regulation of actin filament polymerization
GO_0010629	Biological process	negative regulation of gene expression
GO_0010810	Biological process	regulation of cell-substrate adhesion
GO_0034115	Biological process	negative regulation of heterotypic cell-cell adhesion
GO_0044860	Biological process	protein localization to plasma membrane raft
GO_0001933	Biological process	negative regulation of protein phosphorylation
GO_0030335	Biological process	positive regulation of cell migration
GO_1900026	Biological process	positive regulation of substrate adhesion-dependent cell spreading
GO_0061028	Biological process	establishment of endothelial barrier
GO_0031579	Biological process	membrane raft organization
GO_0045217	Biological process	cell-cell junction maintenance
GO_0001726	Cellular component	ruffle
GO_0005886	Cellular component	plasma membrane
GO_0045121	Cellular component	membrane raft
GO_0030864	Cellular component	cortical actin cytoskeleton
GO_0005911	Cellular component	cell-cell junction
GO_0005515	Molecular function	protein binding
GO_0003674	Molecular function	molecular_function

IV. Literature review

[source]

Gene name	MYADM
Protein name	Myeloid-associated differentiation marker (Protein SB135) Myeloid associated differentiation marker
Synonyms	UNQ553/PRO1110
Description
Accessions	C9JZL8 ENST00000448420.5 C9JC07 ENST00000414489.1 ENST00000391769.2 ENST00000391770.9 ENST00000421337.6 ENST00000651087.1 C9JJV6 A0A494C017 ENST00000439000.5 Q96S97 ENST00000391768.2 ENST00000336967.8 ENST00000391771.1 A0A499FIY8

MYADM report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review